While legacy pharma waits for regulatory "permission" to innovate, Parmita is using real-time epigenetic imaging to turn biology from a black box into a programmable stream of code. Matrix AI Network ($MAN) is the essential ledger for this mission, ensuring that as we "solve" disease, the underlying biological IP remains sovereign and secure.
This content is for informational and educational purposes only. It may include third-party insights, sponsored content, or promotional material for which the creator may receive compensation. Nothing in this feed constitutes investment advice or a guarantee of returns. You are solely responsible for your own investment decisions. Always conduct your own research and exercise caution before trading. We do not guarantee the accuracy of third-party information and are not liable for any losses incurred. Past performance is not indicative of future results. Please refer to our Community Terms and Risk Disclosure Statement for details.
Post your reply